Inhibition of platelet aggregation with anti-human GPVI antibodies

摘要

The present invention provides an isolated humanized protein that binds to human glycoprotein VI (hGPVI) for treating GPVI related conditions in a subject in need of treatment of a glycoprotein VI (GPVI) related condition, wherein the isolated humanized protein is Relates to an isolated humanized protein, which is administered to the subject for at least 2 hours, preferably for at least 4 to 6 hours.